2023

Favorable clinical efficacy of mepolizumab on the upper and lower airways in severe eosinophilic asthma: a 48-week pilot study

M. Kurosawa motohiro@kl.wind.ne.jp ¹, K. Ogawa², E. Sutoh^1,2

Vol. 51 (No. 5) 2019 September

Original Article

doi: 10.23822/EurAnnACI.1764-1489.94

Show more: Authors information and Publication history

Authors Information

¹Department of Allergy and Respiratory Medicine, Sutoh Hospital, Annaka, Gunma, Japan
²Department of Radiology, Sutoh Hospital, Annaka, Gunma, Japan

History

Published online: 12 April 2019
Accepted: 25 March 2019
Received: 30 Januaru 2019

Full text PDF

Table of Content: Vol. 51 (No. 5) 2019 September

Review

Metabolic interactions in asthma

M. Farraia mariana.farraia@gmail.com ^1,2, J. Cavaleiro Rufo¹, I. Paciência^1,2,3, F. Castro Mendes², L. Delgado^4,5, J. Laerte Boechat⁶, A. Moreira^1,2,7

doi: 10.23822/EurAnnACI.1764-1489.101

Download PDF

Letter to the Editor

Availability of epinephrine auto-injectors and knowledge of community pharmacists about their use

C. Pitsios pitsios.constantinos@ucy.ac.cy, A. Vasiliadis, K.P. Karakatsanis, R. Matzaras, T. Minasidis, A. Nteveros, G. Samanis, G. Nikolopoulos

doi: 10.23822/EurAnnACI.1764-1489.106

Download PDF

Original Article

Quality of life improvement with allergen immunotherapy treatment in patients with rhinoconjunctivitis in real life conditions. Results of an observational prospective study (ÍCARA)

J. Cuesta-Herranz¹, J.J. Laguna², R. Mielgo³, I. Pérez-Camo⁴, A.M. Callejo⁵, L. Begoña leire.begona@roxall.es ⁶, M.C. Gomez⁶, B. Madariaga⁶, A. Martinez⁶

doi: 10.23822/EurAnnACI.1764-1489.104

Download PDF

Original Article